Researchers plan to test intravenous drug candidate for Alzheimer's

05/4/2010 | KENS-TV (San Antonio)

Researchers at the University of Texas Health Science Center at San Antonio are preparing to conduct a trial of an experimental drug for Alzheimer's disease. The drug, solanezumab, is administered intravenously monthly and is intended to target amyloid plaques in the brain. To measure the drug's effectiveness, study participants will undergo PET scans.

View Full Article in:

KENS-TV (San Antonio)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ